On the contrary, over-expression of CCL2 in a murine APP/CCL2 model or CCR2 deficiency in several mouse AD models led to an accelerated β-amyloidosis, astrogliosis, microgliosis, and cognitive dysfunctions [91, 92]. This evidence concerns the gene CCL2 and Alzheimer disease.